Leigh Anne Eller

5PUBLICATIONS
55CO-AUTHORS
Epidemiological methodsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 02, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah

|Mar 18, 2022
HIV-1 infections with multiple founders associate with the development of neutralization breadth.

Eric Lewitus, Samantha M Townsley, Yifan Li

|Feb 07, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.

Morgane Rolland, Sodsai Tovanabutra, Bethany Dearlove

|Sep 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R- Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity.

Prossy Naluyima, Kerri G Lal, Margaret C Costanzo

|Aug 01, 2017
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Gustavo H Kijak, Eric Sanders-Buell, Agnes-Laurence Chenine

Pageof 1

Frequent Collaborators

4 joint publications

Merlin L Robb

3 joint publications

Michael A Eller

3 joint publications

Morgane Rolland

2 joint publications

Gustavo Kijak